29 Aug 2025
❌FDA Terminates Arthritis Advisory Committee – Regulatory Update
Advisory Committee; Arthritis Advisory Committee; Termination; Removal From List of Standing Committees
Summary
The Food and Drug Administration (FDA or the Agency) is announcing the termination of the Arthritis Advisory Committee (Committee). Due to that termination, this final rule removes the Committee from the Agency's list of standing advisory committees in 21 CFR 14.100.
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$ - Low
The text describes the termination of the Arthritis Advisory Committee and amendments to 21 CFR Part 14. This regulatory change primarily focuses on internal FDA procedural adjustments rather than imposing new compliance or financial obligations on businesses.